Congenital Hyperinsulinism clinical trials at UCSF

• 18FluoroLDOPA PET Imaging for the Detection and Localization of Focal Congenital Hyperinsulinism

  open to eligible people ages up to 18 years

  The goal of this project is to determine the role of FDOPA/PET as a pre-operative diagnostic imaging procedure for differentiating focal and diffuse forms of congenital hyperinsulinism and locating focal lesions in the pancreas to guide surgical resection.

  San Francisco, California

Last updated: December 17, 2019